<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04144829</url>
  </required_header>
  <id_info>
    <org_study_id>Intima1/2019</org_study_id>
    <nct_id>NCT04144829</nct_id>
  </id_info>
  <brief_title>Platelet-rich Fibrin Versus HIFU in Management of Stress Urinary Incontinence</brief_title>
  <official_title>Platelet-rich Fibrin Versus HIFU in Management of Stress Urinary Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intima Clinic</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Intima Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of the study is to compare effect of High Intensity Focused Ultrasound (HIFU) and
      platelet-rich fibrin in management of stress urinary incontinence.

      It is a randomized prospective study. After assigning to one of the two groups, patients will
      undergo relevant treatment.

      First group will undergo 3 cycles of intravaginal HIFU treatment in 6-weeks interval.

      Second group will undergo 3 injections of platelet-rich fibrin under urethra. Before the
      treatment and after 2, 6 and 12 months after treatment is finished patients will be asked to
      fill questionaries concerning quality of life ICIQ-UI SF, ICIQ-LUTS, PISQ12, FSFI.

      Before each treatment cycle patients will be examined and asked to fill daily micturition
      plan.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">August 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of patient's comfort and satisfaction</measure>
    <time_frame>1 year</time_frame>
    <description>Improvement of patient's comfort and satisfaction measured in questionnaire ICIQ-UI SF (International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form), scale 0-21 points, higher score meaning worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Improvement of patient's comfort and satisfaction</measure>
    <time_frame>1 year</time_frame>
    <description>Improvement of patient's comfort and satisfaction measured in questionnaire FSFI (Female Sexual Function Index), score 2-36, higher score meaning better outcome</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Stress Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>HIFU</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3 cycles of HIFU treatment in 6-week intervals</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fibrin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3 cycles of platelet-rich fibrin injection treatment in 6-week intervals</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>HIFU</intervention_name>
    <description>Intravaginal HIFU procedure, lengths 1.5, 3 and 4.5 mm - 200, 200 and 100 impulses respectively</description>
    <arm_group_label>HIFU</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fibrin</intervention_name>
    <description>Injection of 2ml platelet-rich fibrin from centrifuged for 5 min patient's blood under the urethra</description>
    <arm_group_label>Fibrin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  stress urinary incontinence of low grade

          -  separate episodes of urinary incontinence (associated with increase of abdominal
             pressure)

          -  no cystocoele or cystocoele POPQ1

          -  positive cough test when filled bladder

        Exclusion Criteria:

          -  POPQ 2 and more

          -  patients after urogenital operations or radiation

          -  neuromuscular, hematologic, autoimmune, uncontrolled psychiatric diseases

          -  uncontrolled diabetes

          -  pregnancy, lactation

          -  patients undergoing conservative treatment for stress urinary incontinence

          -  ASA or other anti-platelet drug intake less than 7 days before and 7 days after
             procedure

          -  active carcinomas or status less than 5 years after treatment

          -  sepsis

          -  infection in treated region
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tomasz Basta, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Intima Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tomasz Basta, PhD</last_name>
    <phone>501295424</phone>
    <email>tomaszbasta@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anna Horbaczewska, MD</last_name>
    <phone>603307027</phone>
    <email>anna.horbaczewska@yahoo.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Intima Clinc</name>
      <address>
        <city>Krakow</city>
        <state>Malopolskie Voivodeship</state>
        <zip>31-559</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tomasz Basta, PhD</last_name>
      <phone>501295424</phone>
      <phone_ext>0048</phone_ext>
      <email>tomaszbasta@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Anna Horbaczewska, MD</last_name>
      <phone>603307027</phone>
      <phone_ext>0048</phone_ext>
      <email>anna.horbaczewska@yahoo.pl</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>October 27, 2019</study_first_submitted>
  <study_first_submitted_qc>October 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2019</study_first_posted>
  <last_update_submitted>November 1, 2019</last_update_submitted>
  <last_update_submitted_qc>November 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Intima Clinic</investigator_affiliation>
    <investigator_full_name>Tomasz Basta</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

